Integral Diagnostics |
High $3.28 |
Low $3.15 |
Trades 1,211 |
Turnover $2,399,883 |
Volume 745,243 |
| 30 June 2023 at 4:10pm | ||||
|
Market Cap (13-Nov) $635,284,800 (313th) |
Close (30-Jun) $3.28 |
Volume (30-Jun) 745,243 |
Shortsold (6-Nov) 7,492,021 (2.00%) (166th) |
|
52w High $2.60 |
52w Low $1.68 |
P/E 16.18 |
EPS 0.06 |
FY22 Investor Presentation
IDX released this announcement to the ASX on 29 August 2022, 8:10. The announcement is marked as price sensitive, and is 27 page(s) in length and 1.97MB in size.
You can view all announcements from IDX and see how they appear on a price chart on the announcements page.
At the date of this announcement, IDX was 1.746% short sold according to ASIC data. It was ranked the 142nd most shorted stock on the ASX. It remains ranked 166th as of the latest reported data (06 November 2026).
| Other Recent Announcements from IDX | |
|---|---|
| Release from Escrow | 20 June 2023, 9:25 |
| Change in substantial holding | 9 May 2023, 17:01 |
| Change of Director's Interest Notice - John Atkin | 5 April 2023, 13:07 |
| FY22 Investor Presentation | 29 August 2022, 8:10 |
| FY22 Results Announcement | 29 August 2022, 8:09 |
| Dividend/Distribution - IDX | 29 August 2022, 8:09 |
| Appendix 4E and Annual Report to shareholders | 29 August 2022, 8:08 |
If you were already registered, log in here.